NEW YORK (GenomeWeb News) – Satoris will use Xennex's GeneCards database and other tools in its biomarker studies, under a new agreement announced by Xennex today.
The agreement gives Satoris access to GeneCards, which is a searchable integrated database of human genes for use in genomic, proteomic, transcriptomics, and genetic functional information on all known and predicted human genes.
Satoris will use the database in its protein biomarker research. It is seeking markers for neurological diseases such as Alzheimer's, Parkinson's, multiple sclerosis, and diabetic neuropathy.
The agreement also gives Satoris access to related tools and early access to input from the new GeneCards version 3.0 prototype, which is currently "in advanced stages of development," Xennex said.
Financial terms of the agreement were not released.